Seaport Therapeutics, Inc. (SPTX)Healthcare | Biotechnology | Boston, United States | NasdaqGS
20.10 USD
-1.48
(-6.858%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 20.10 |
Hot Take ↕ | July 11, 2026, 6:28 a.m. EDT
The immediate outlook is neutral due to a lack of statistical data to confirm short-term momentum, despite recent price volatility. However, the long-term investment case is severely compromised by deteriorating fundamentals; the company reports negative earnings, negative book value, and negative operating cash flow, indicating a business that is currently burning capital without generating returns. This financial distress is compounded by a significant multi-year price decline, suggesting the market has already priced in substantial structural deterioration. Furthermore, there is no dividend income to offset these risks, making this a speculative biotech play rather than a viable investment vehicle. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.547 |
| Market Cap | 1,075,964,160 |
| Forward P/E | -8.26 |
| Website | https://www.seaporttx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.08770156 |
| Address1 | 101 Seaport Blvd. |
| Address2 | Floor 12 |
| All Time High | 23.0 |
| All Time Low | 14.85 |
| Ask | 20.74 |
| Ask Size | 1 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 191,660 |
| Average Daily Volume3 Month | 373,806 |
| Average Volume | 373,806 |
| Average Volume10Days | 191,660 |
| Bid | 19.48 |
| Bid Size | 1 |
| Book Value | -44.549 |
| City | Boston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 20.1 |
| Current Ratio | 13.242 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 21.56 |
| Day Low | 20.07 |
| Debt To Equity | 2.547 |
| Display Name | Seaport Therapeutics |
| Ebitda | -96,024,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -12.747 |
| Enterprise Value | 1,224,029,056 |
| Eps Current Year | -5.57518 |
| Eps Forward | -2.4332 |
| Eps Trailing Twelve Months | -1.64 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 18.005625 |
| Fifty Day Average Change | 2.0943756 |
| Fifty Day Average Change Percent | 0.11631785 |
| Fifty Two Week Change Percent | 8.770156 |
| Fifty Two Week High | 23.0 |
| Fifty Two Week High Change | -2.8999996 |
| Fifty Two Week High Change Percent | -0.12608694 |
| Fifty Two Week Low | 14.85 |
| Fifty Two Week Low Change | 5.25 |
| Fifty Two Week Low Change Percent | 0.35353535 |
| Fifty Two Week Range | 14.85 - 23.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,777,642,200,000 |
| Float Shares | 28,294,108 |
| Forward Eps | -2.4332 |
| Forward P E | -8.260727 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 58 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.35056 |
| Held Percent Institutions | 0.31897 |
| Implied Shares Outstanding | 53,530,550 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-05-01 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts. |
| Long Name | Seaport Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 1,075,964,160 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1877598160 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -87,164,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,163,754,157 |
| Number Of Analyst Opinions | 4 |
| Open | 21.335 |
| Operating Cashflow | -77,909,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | (617) 807-4062 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 20.1 |
| Post Market Time | 1,783,973,405 |
| Previous Close | 21.58 |
| Price Eps Current Year | -3.605265 |
| Price Hint | 2 |
| Price To Book | -0.4511886 |
| Profit Margins | 0.0 |
| Quick Ratio | 13.069 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.6 |
| Region | US |
| Regular Market Change | -1.48 |
| Regular Market Change Percent | -6.8582 |
| Regular Market Day High | 21.56 |
| Regular Market Day Low | 20.07 |
| Regular Market Day Range | 20.07 - 21.56 |
| Regular Market Open | 21.335 |
| Regular Market Previous Close | 21.58 |
| Regular Market Price | 20.1 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 62,802 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 53,530,550 |
| Shares Percent Shares Out | 0.0519 |
| Shares Short | 2,779,385 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,752,377 |
| Short Name | Seaport Therapeutics, Inc. |
| Short Percent Of Float | 0.0546 |
| Short Ratio | 11.66 |
| Source Interval | 15 |
| State | MA |
| Symbol | SPTX |
| Target High Price | 40.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 35.0 |
| Target Median Price | 35.0 |
| Total Cash | 182,604,992 |
| Total Cash Per Share | 3.411 |
| Total Debt | 5,342,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 18.005625 |
| Two Hundred Day Average Change | 2.0943756 |
| Two Hundred Day Average Change Percent | 0.11631785 |
| Type Disp | Equity |
| Volume | 62,802 |
| Website | https://www.seaporttx.com |
| Zip | 02,210-2186 |